Financial reports
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
28 Mar 22
10-Q
2021 Q3
Quarterly report
5 Nov 21
10-Q
2021 Q2
Quarterly report
19 Aug 21
NT 10-Q
Notice of late quarterly filing
17 Aug 21
10-Q
2021 Q1
Quarterly report
24 May 21
NT 10-Q
Notice of late quarterly filing
18 May 21
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10 Apr 23
8-K
Termination of a Material Definitive Agreement
7 Apr 23
8-K
Pear Therapeutics Announces Process Exploring Strategic Alternatives
17 Mar 23
8-K
Departure of Directors or Certain Officers
24 Feb 23
8-K
Entry into a Material Definitive Agreement
3 Jan 23
8-K
Pear Therapeutics Reports Third Quarter 2022 Results
14 Nov 22
8-K
Pear Therapeutics Reports Second Quarter 2022 Results
11 Aug 22
8-K
Cost Associated with Exit or Disposal Activities
25 Jul 22
8-K
Regulation FD Disclosure
24 Jun 22
8-K
Pear Therapeutics Announces Three New Board Members
15 Jun 22
Registration and prospectus
25-NSE
Exchange delisting
2 May 23
S-8
Registration of securities for employees
9 Feb 23
424B5
Prospectus supplement for primary offering
10 Jan 23
424B3
Prospectus supplement
4 Jan 23
POS AM
Prospectus update (post-effective amendment)
3 Jan 23
424B3
Prospectus supplement
3 Jan 23
S-3
Shelf registration
3 Jan 23
424B3
Prospectus supplement
14 Nov 22
424B3
Prospectus supplement
11 Aug 22
424B3
Prospectus supplement
25 Jul 22
Other
EFFECT
Notice of effectiveness
12 Jan 23
CORRESP
Correspondence with SEC
6 Jan 23
UPLOAD
Letter from SEC
6 Jan 23
EFFECT
Notice of effectiveness
4 Jan 23
EFFECT
Notice of effectiveness
30 Mar 22
EFFECT
Notice of effectiveness
3 Jan 22
CORRESP
Correspondence with SEC
29 Dec 21
UPLOAD
Letter from SEC
29 Dec 21
EFFECT
Notice of effectiveness
27 Oct 21
SEC STAFF
SEC staff action: Order
26 Oct 21
Ownership
SC 13D/A
JAZZ Human Performance Opportunity Fund, LP
28 Apr 23
4
SCOTT M ROCKLAGE
12 Apr 23
SC 13D/A
5AM Ventures IV, L.P.
12 Apr 23
4
Ellen Snow
17 Feb 23
4
Erin K. Brenner
17 Feb 23
4
Ronan O'Brien
17 Feb 23
4
Yuri Maricich
17 Feb 23
4
Julia Strandberg
17 Feb 23
4
CHRISTOPHERD T GUIFFRE
17 Feb 23
4
Corey McCann
17 Feb 23